Keyphrases
Spermine
100%
Breast Adenocarcinoma
100%
Genistein
100%
Doxorubicin
100%
Antiangiogenic
100%
Intracellular Localization
100%
Multifunctional Hybrids
100%
Hybrid Nanoconstructs
100%
Heparan Sulfate Proteoglycans
75%
Tumor Microenvironment
50%
Efficient Delivery
50%
Apoptosis
25%
Mitochondrial Membrane Potential
25%
Tumor
25%
Cell Surface
25%
Quantitative PCR
25%
Angiogenesis
25%
Mouse Model
25%
Western Blotting
25%
Synergistic Interaction
25%
Targeted Treatment
25%
Antiangiogenic Agents
25%
Delivery System
25%
Hypoxia-inducible factor-1α (HIF-1α)
25%
MDA-MB-231
25%
Human Breast Cancer Cells
25%
PH Dependence
25%
MDA-MB-231 Cells
25%
Receptor-mediated Endocytosis
25%
Human Umbilical Vein Endothelial Cells (HUVECs)
25%
VEGF Pathway
25%
Promising Strategies
25%
Pro-apoptotic
25%
Combination Chemotherapy
25%
Specific Uptake
25%
Intracellular pH
25%
Progressive Development
25%
Antiangiogenic Activity
25%
LiPo
25%
Pathway Modulation
25%
In Silico Docking
25%
Hybrid Nanoparticles
25%
Charge Reversal
25%
Synergistic Drug Delivery
25%
Pharmacology, Toxicology and Pharmaceutical Science
Doxorubicin
100%
Genistein
100%
Spermine
100%
Antiangiogenic
100%
Breast Adenocarcinoma
100%
Proteoheparan Sulfate
75%
Tumor Microenvironment
50%
Receptor
50%
Vasculotropin
50%
Malignant Neoplasm
25%
Western Blot
25%
Neoplasm
25%
Chemotherapy
25%
Breast Cancer
25%
Mouse Model
25%
Protein Kinase B
25%
Nanoparticle
25%
Angiogenesis Inhibitor
25%
Receptor-Mediated Endocytosis
25%
Neuroscience
Spermine
100%
Doxorubicin
100%
Genistein
100%
Proteoheparan Sulfate
75%
Receptor
75%
Vascular Endothelial Growth Factor
50%
Mitochondrial Membrane Potential
25%
In Vitro
25%
In Vivo
25%
Western Blot
25%
Angiogenesis
25%
Endocytosis
25%
Angiogenesis Inhibitor
25%
Protein Kinase B
25%
Chemotherapy
25%
Programmed Cell Death
25%
Biochemistry, Genetics and Molecular Biology
Doxorubicin
100%
Genistein
100%
Proteoglycan
75%
Heparan Sulfate
75%
Vascular Endothelial Growth Factor
50%
Cancer Cell
25%
Mitochondrial Membrane Potential
25%
Angiogenesis
25%
Mouse Model
25%
Protein Kinase B
25%
Reverse Transcription Polymerase Chain Reaction
25%
Downregulation
25%
Western Blot
25%
Endocytosis
25%
Antiangiogenic Activity
25%
Polymerization
25%
Programmed Cell Death
25%
Immunology and Microbiology
Proteoglycan
100%
Vasculotropin
66%
Cell Surface
33%
Western Blot
33%
Cancer Cell
33%
Mouse Model
33%
Angiogenesis
33%
Downregulation
33%
Reverse Transcription Polymerase Chain Reaction
33%
Endocytosis
33%
Mitochondrial Membrane Potential
33%
Polymerization
33%
Angiogenesis Inhibitor
33%
Antiangiogenic Activity
33%
Programmed Cell Death
33%